In its latest bid to rein in the health care industry, the Federal Trade Commission filed a lawsuit accusing Surescripts of illegally monopolizing the market for e-prescribing, which refers to transmitting patient information and prescriptions among insurers, doctors, and pharmacies.

E-prescribing has becoming an important component of health care as public and private payers, as well as heath care providers, seek to streamline costs and speed important paperwork among key players. And Surescripts has been a dominant purveyor for more than a decade with a 95% market share, according to the lawsuit, which was filed on April 17 but disclosed by the agency on Wednesday.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy